• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

MELA Sciences

NASDAQ:MELA

$2.69 -$0.08 (-2.89%)

REAL-TIME: Last trade at

This Just In: Upgrades and Downgrades

2 Stocks Stopping the Presses

Here's What George Soros Has Been Buying and Selling

This Just In: Upgrades and Downgrades

Mark Your Calendars, Biotech Investors

Options Market Picks: 9 Highly Liquid Stocks with Bullish Options Sentiment

Options Market Picks: 9 Highly Liquid Stocks With Bullish Options Sentiment

This Just In: More Upgrades and Downgrades

FDA Approves! Investors Shrug.

Mela Sciences' Skin Cancer Detector Gets FDA Nod

3 Stocks Shaking the Market

Whoa! What Just Happened to My Stock?

Whoa! My Stock Just Crushed the Market!

Mela Rallies on Likely Approval of Skin Cancer Device

Closer to Approval, Now Can MELA Find Customers?

3 Stocks Shaking the Market

One Hot Stock to Avoid

All Approvals Are Not Created Equal

Mela Sciences Soars on EU Approval of Skin Cancer Device

Mela Science's Skin Cancer Detector Approved in EU

This Just In: Upgrades and Downgrades

Running the Correct Trial Isn't Enough

The 15 Most-Watched Medical-Device Stocks

This Just In: More Upgrades and Downgrades

Warning Biotech Investors: FDA Advisory Panels' No Means No, Yes Means Maybe

4 Small Caps Likely to Rebound?

4 Small Caps That Could Pop

Six Great Growth Stocks

Friday Options Recap

Mid-Day Update: Selloff in Full Force at Mid-Day as Investors Focus on Monetary, Economic Issues Abr

Stocks Descending in Mid-Day Trading; Europe, China Worries Dominate Investor Focus

Tuesday Options Recap

Mela Sciences Surges Ahead of FDA Panel

Why Bears Expect MELA to Plunge

Trading MELA Sciences' Pending FDA Decision

10 Year-End Stock Trades on FDA Binary Events

Analyst Calls: BCR, BUD, CLX, CMA, CSC, CSCO, DELL, LEN, MCO, NOK, TRV ...

9 Heavily Shorted Stocks Reporting Earnings This Week

30 Stocks Showing Excessive Pessimism

Eight Trades on FDA, Clinical Trial Binary Events

See More Articles...